PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF POST-SURGICAL PAIN

Abstract

The present invention relates to an anti-IL-6 agent for use in a method of preventing or treating post-operative pain in an individual.

Description

Claims

1. An anti-IL-6 agent for use in a method of preventing or treating post-operative pain in an individual.

2. The anti-IL-6 agent for use according to claim 1, wherein the anti-IL-6 agent is an immunotherapeutic agent.

3. The anti-IL-6 agent for use claim 1, wherein the anti-IL-6 agent is a passive immunotherapy agent.

4. The anti-IL-6 agent for use claim 1, wherein the anti-IL-6 agent is an anti-IL-6 or anti-IL-6R antibody, in particular monoclonal antibody, or an IL-6 or IL-6R binding portion of an antibody.

5. The anti-IL-6 agent for use claim 1, wherein the anti-IL-6 agent is an active immunotherapy agent.

6. The anti-IL-6 agent for use claim 1, wherein the anti-IL-6 agent comprises, or consists of, a polypeptide derived from IL-6 or the IL-6 receptor (IL-6R), optionally bound to a carrier protein.

7. The anti-IL-6 agent of claim 6, wherein the polypeptide comprises, or consists of, a sequence of at least 6 amino acid residues of IL-6 or IL-6R or a sequence having at least 90% identity thereto.

8. The anti-IL-6 agent for use according to claim 1, wherein the agent is selected from the group consisting of an IL-6 receptor or an IL-6 binding portion thereof or an anti-IL-6 aptamer.

9. The anti-IL-6 agent for use claim 1, wherein post-operative pain is not immediate.

10. The anti-IL-6 agent for use claim 1, wherein the post-operative pain is subsequent to arthroplasty, in particular of the knee or hip, thoracic surgery, in particular cardiac surgery, thoracotomy or sternotomy, breast surgery, hernia surgery, hysterectomy, cholecystectomy, arthroscopy of the knee, or caesarean section.